Massive study aims to perfect testicular cancer aftercare

NCT ID NCT02229916

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study follows 6,900 men treated for testicular cancer to find the best way to detect cancer return and manage long-term side effects. Participants will have regular check-ups using scans, blood tests, and exams. The goal is to create standard follow-up guidelines that catch relapses early while avoiding unnecessary tests and radiation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TESTICULAR NEOPLASMS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Kantonsspital St.Gallen; Onkologie/Haematologie

    RECRUITING

    Sankt Gallen, 9007, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.